Most people are aware of generic drugs and how much more inexpensive they are than their comparable brand name pharmaceuticals. But you may not know that there are new generic-type medications on the market known as biosimilars, that treat chronic diseases such as Crohn’s Disease, cancer, and Rheumatoid Arthritis that are much lower in cost than their comparables known as biologics. But our next guest says that they are not yet available in our state because our laws don’t address them yet.
Mike Switzer interviews Phyllis Henderson, a member of the South Carolina House of Representatives, serving Greenville’s District 21 since 2010. She also chairs the Healthcare Subcommittee of the Legislative Oversight Committee.
